Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blockers and Bone Metabolism in Postmenopausal Women
NCT02467400Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of propranolol, atenolol and nebivolol in osteoporosis (5 arms), sponsored by Mayo Clinic. Primary endpoint: Ratio of serum bone formation to bone resorption marker at 20 weeks. Started Jul 2015; status: completed.
02
Drugs
propranololatenololnebivolol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02467400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467400.